In a first, FDA signs off on Cell­Tran­s' type 1 di­a­betes cell ther­a­py days af­ter in­dus­try's eyes fix­at­ed on Ver­tex da­ta

Cer­tain pa­tients with type 1 di­a­betes now have an op­tion to use cell ther­a­py thanks to a new FDA ap­proval.

The agency green­lit on Wednes­day Cell­Trans’ pan­cre­at­ic islet cell ther­a­py, which takes pan­cre­at­ic cells from de­ceased donors. FDA OK’d the first-of-its-kind cell ther­a­py, known as Lan­tidra or don­isle­cel, for pa­tients who are un­able to ap­proach av­er­age blood glu­cose lev­els be­cause of low blood sug­ar even af­ter in­ten­sive man­age­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER